1. Nalianda KK, Rathen MM, Jagadeesan S, Shenoy D P. Mimics of scleroderma. Indian J Rheumatol [serial online] 2017 [cited 2020 Nov 24];12, Suppl S1:171-9.

Available from: https://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=171;epage=179;aulast=Nalianda

2. Shanoj K C, Joseph S, Shenoy P. Drug reaction with eosinophilia and systemic symptoms syndrome. Indian J Rheumatol [serial online] 2019 [cited 2020 Nov 24];14, Suppl S1:59-66.

Available from: https://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=5;spage=59;epage=66;aulast=Shanoj

3. Shenoy PD, Kumar S, Jha LK, Choudhary SK, Singh U, Misra R, Agarwal V. Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology (Oxford). 2010 Dec;49(12):2420-8. doi: 10.1093/rheumatology/keq291. Epub 2010 Sep 12. PMID: 20837499.

Available from: https://pubmed.ncbi.nlm.nih.gov/20837499/

4. Shenoy P. Agarwal V. inhibitors in the management of autoimmune disease Autoimmunity Reviews;2010(9)' 511-515

5. Amalnath SD, Subramanyam DK, Dutta TK, Shenoy P. Familial oculoauriculovertebral sequence with lymphoma In one sibling. Am J Med Genet A. 2008 Dec 1;146A (23):3082-5. Shenoy P, Misra R, Jain M, Agarwal V. (PDF) Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome (researchgate.net) N Z Med J. 2008;121:102-5

6. Shenoy P, Aggarwal A lmmunopathogenesis of Systemic lupus erythematosus. Moves, April 2008; 1-6.

7. Pavithran P, Nandeesha H Shenoy P, Sunii S Dyslipidemia antedates occurrence of clinical hypertension in non-diabetic, non-obese male subjetcs. Indian J Physiol Pharmacol. 2007;5'l(1):96-8

8. Shenoy P, Ganesan P, Swaminathan RP. Systemic hypertension due to compression of the kidney by a pancreatic pseudocyst Eur J intern Med. 2007;18(6):507-8.
Systemic hypertension due to compression of the kidney by a pancreatic pseudocyst - PubMed (nih.gov)

9. Raj M, Ramakrishnan A. Shenoy P, Negi VS, Swaminathan RP. Asymptomatic right atrial thrombus in a case of nephrotic syndrome. J Nephrol.2006;19(6)'825-7

10. Shenoy, P., Ahmed, S., Paul, A. et al. Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India. Clin Rheumatol 39, 2757–2762 (2020). https://doi.org/10.1007/s10067-020-05200-6

Available from: https://link.springer.com/article/10.1007/s10067-020-05200-6#citeas

11. C SK, Ahmed S, Shenoy V, Menon AR, Saijan S, Babu SA, Shenoy P. Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'. Ann Rheum Dis. 2021 Mar 10:annrheumdis-2021-220148. doi: 10.1136/annrheumdis-2021-220148. Epub ahead of print. PMID: 33692021.

Available from: https://ard.bmj.com/content/early/2021/03/09/annrheumdis-2021-220148

12. Cherian, S., Paul, A., Ahmed, S. et al. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int 41, 1441–1445 (2021). https://doi.org/10.1007/s00296-021-04917-0

Available from: https://link.springer.com/article/10.1007/s00296-021-04917-0

13. Shenoy P, Ahmed S, Paul A, Cherian S, Vijayan A, Babu SA, Sukumaran A. Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseases. Ann Rheum Dis. 2022 Feb;81(2):295-296. doi: 10.1136/annrheumdis-2021-221496. Epub 2021 Oct 11. PMID: 34635493.

Available from: https://ard.bmj.com/content/81/2/295

14. Shenoy P, Ahmed S, Paul A, Cherian S, Umesh R, Shenoy V, Vijayan A, Babu S, S N, Thambi A. Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases. Lancet Rheumatol. 2022 Feb;4(2):e80-e82. doi: 10.1016/S2665-9913(21)00356-8. Epub 2021 Nov 22. PMID: 34841270; PMCID: PMC8608390.

Available from: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00356-8/fulltext

15. Shenoy P, Ahmed S, Shanoj KC, Shenoy V, Damodaran D, Menon AR, Alias B, SanjoSaijan, Devakumar D, Babu ASS. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease. Clin Rheumatol. 2021 Nov;40(11):4665-4670. doi: 10.1007/s10067-021-05801-9. Epub 2021 Jun 22. PMID: 34155573; PMCID: PMC8216872.

Available from: https://link.springer.com/article/10.1007/s10067-021-05801-9

16. Vijayan A, Ahmed S, Joseph S, Sukumaran A, Ahmed S, Shenoy P. Effects of face masks on oxygen saturation and functional measures in patients with connective tissue disorder-associated interstitial lung disease. Ann Rheum Dis. 2021 Nov;80(11):1497-1498. doi: 10.1136/annrheumdis-2021-220230. Epub 2021 May 10. PMID: 33972260.

Available from: https://ard.bmj.com/content/80/11/1497

17. Kavadichanda C, Shobha V, Ghosh P, Wakhlu A, Bairwa D, Mohanan M, Janardana R, Sircar G, Sahoo RR, Joseph S, Negi VS, Khanna D, Shenoy P. Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR). Rheumatol Adv Pract. 2021 Apr 23;5(2):rkab027. doi: 10.1093/rap/rkab027. PMID: 34095747; PMCID: PMC8135468.

Available from: https://academic.oup.com/rheumap/article/5/2/rkab027/6248107?login=false

18. Ahmed S, Mehta P, Paul A, Anu S, Cherian S, Shenoy V, Nalianda KK, Joseph S, Poulose A, Shenoy P. Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort. Ann Rheum Dis. 2022 Jun;81(6):868-874. doi: 10.1136/annrheumdis-2021-221922. Epub 2022 Feb 8. PMID: 35135831.

Available from: https://ard.bmj.com/content/81/6/868